A Phase I Clinical Trial of Fluorouracil (5-FU) + CPI-613 Combination in Previously Treated Metastatic Colorectal Cancer Patients
Phase of Trial: Phase I
Latest Information Update: 16 Mar 2017
At a glance
- Drugs CPI 613 (Primary) ; Fluorouracil (Primary)
- Indications Adenocarcinoma; Colorectal cancer; Rectal cancer
- Focus Adverse reactions
- 17 Dec 2014 Planned primary completion date changed from 1 Oct 2018 to 1 Dec 2018 as reported by ClinicalTrials.gov record.
- 17 Dec 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
- 10 Sep 2014 New trial record